Estrogens conjugated
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
160 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Menopause | D008593 | EFO_0003922 | N95 | 6 | 4 | 4 | 7 | 2 | 23 |
| Postmenopause | D017698 | — | — | 8 | 5 | 3 | 2 | 3 | 21 |
| Atrophy | D001284 | — | — | 2 | — | 5 | 1 | 2 | 10 |
| Carcinoma | D002277 | — | C80.0 | 1 | 6 | 1 | 1 | — | 9 |
| Atrophic vaginitis | D059268 | EFO_1001271 | — | 2 | — | 3 | 3 | 1 | 9 |
| Vaginitis | D014627 | EFO_0005757 | N76 | 3 | — | 1 | 3 | 2 | 9 |
| Hot flashes | D019584 | — | — | — | — | 4 | 2 | 2 | 8 |
| Pelvic organ prolapse | D056887 | EFO_0004710 | — | — | — | 1 | 4 | 2 | 7 |
| Prolapse | D011391 | — | — | — | — | 1 | 4 | 2 | 7 |
| Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | — | — | — | 4 | 2 | 6 |
Show 30 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Prostatic neoplasms | D011471 | — | C61 | 3 | 16 | 10 | — | 2 | 30 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 5 | 9 | 2 | — | 5 | 20 |
| Adenocarcinoma | D000230 | — | — | 1 | 8 | 2 | — | — | 11 |
| Osteoporosis | D010024 | HP_0000939 | M81.0 | 1 | — | 6 | — | 2 | 9 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | 2 | 5 | — | — | 6 |
| Neoplasms | D009369 | — | C80 | — | 3 | 1 | — | — | 4 |
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | 2 | 3 | — | — | 4 |
| Coronary disease | D003327 | — | — | — | 1 | 4 | — | — | 4 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | 1 | 4 | — | — | 4 |
| Coronary artery disease | D003324 | — | I25.1 | — | 1 | 3 | — | — | 3 |
Show 10 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Triple negative breast neoplasms | D064726 | — | — | 1 | 4 | — | — | — | 4 |
| Male breast neoplasms | D018567 | — | — | — | 2 | — | — | 1 | 3 |
| Hypersensitivity | D006967 | HP_0012393 | T78.40 | — | 2 | — | — | — | 2 |
| Lymphatic metastasis | D008207 | EFO_1001364 | — | — | 1 | — | — | — | 1 |
| Risk reduction behavior | D040242 | — | — | — | 1 | — | — | — | 1 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | 1 | — | — | — | 1 |
| Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | 1 | — | — | — | 1 |
| Sclerosis | D012598 | — | — | — | 1 | — | — | — | 1 |
| Carcinoma in situ | D002278 | — | D09.9 | — | 1 | — | — | — | 1 |
| Breast carcinoma in situ | D000071960 | — | D05 | — | 1 | — | — | — | 1 |
Show 22 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 6 | — | — | — | — | 6 |
| Primary ovarian insufficiency | D016649 | EFO_0004266 | E28.3 | 2 | — | — | — | 1 | 3 |
| Estrogen replacement therapy | D015914 | — | — | 2 | — | — | — | — | 2 |
| Postmenopausal osteoporosis | D015663 | EFO_0003854 | — | 1 | — | — | — | 1 | 2 |
| Premature menopause | D008594 | HP_0008209 | E28.31 | 2 | — | — | — | — | 2 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 1 | — | — | — | — | 1 |
| Sleep | D012890 | GO_0030431 | — | 1 | — | — | — | — | 1 |
| Metrorrhagia | D008796 | HP_0100608 | N92.1 | 1 | — | — | — | — | 1 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | — | 1 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | — | — | — | — | 1 |
Show 3 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | — | 1 | 1 |
| Postoperative pain | D010149 | — | G89.18 | — | — | — | — | 1 | 1 |
| Gender dysphoria | D000068116 | — | — | — | — | — | — | 1 | 1 |
| Breast density | D000071060 | — | — | — | — | — | — | 1 | 1 |
| Dementia | D003704 | EFO_0003862 | F03 | — | — | — | — | 1 | 1 |
| Heart failure | D006333 | HP_0001635 | I50 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
917 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use